ライフサイエンスコーパス: intent

1 new localized cancers treated with curative intent.

2 ocal therapy to the liver mass with curative intent.

3 ten make inferences about the transgressor's intent.

4 or, its lethality, and suicidal ideation and intent.

5 orectal cancer (CRC) resection with curative intent.

6 sk of recurrence after surgery with curative intent.

7 ormed for all patients treated with curative intent.

8 urgery in Taiwan is primarily for palliative intent.

9 treatment of colorectal cancer with curative intent.

10 ssified procedures according to their likely intent.

11 ems not to be curative, despite its curative intent.

12 moradiotherapy or radiotherapy with curative intent.

13 osed HIV-cHL should be managed with curative intent.

14 treatment arm were allowed to heal by second intent.

15 of carboplatin and paclitaxel with curative intent.

16 nd response strategies to hints of microbial intent.

17 toperative systemic chemotherapy of curative intent.

18 cancer after initial treatment with curative intent.

19 re in GIST patients treated with neoadjuvant intent.

20 ween open and MI esophagectomy with curative intent.

21 diation and had been treated with a curative intent.

22 tivated by (i) self-interest or (ii) harmful intent.

23 ns in GIST patients treated with neoadjuvant intent.

24 with incident HPV-OPC treated with curative intent, 124 had 1 or more posttreatment oral rinses avai

25 15 (7%) patients who had undergone curative-intent ablation, surgery, or liver transplantation were

26 enter an era in which surgery with curative intent actually fulfills this goal on a much more regula

27 from hospitalization through 2011 by injury intent among 3 groups were compared.

28 from 2001 through hospitalization by injury intent among 3 groups were compared.

29 , NNT to benefit 46) and the neuroprotective intent analysis (RR 0.68, 95% CI 0.53 to 0.87, 3,988 bab

30 orbidities can undergo therapy with curative intent and achieve successful long-term outcome.

31 lity of neural decoding for both users' gait intent and continuous kinematics.

32 ural interfaces are designed to decode motor intent and evoke sensory precepts in amputees.

33 hality of past suicide attempts and suicidal intent and ideation.

34 ential predicts future suicidal ideation and intent and lethality of future suicide attempts.

35 one urban, one rural) in the extent to which intent and mitigating circumstances influence moral judg

36 Intent and mitigating circumstances play a central role

37 elf-inflicted injuries, misclassification of intent, and ascertainment bias.

38 nd patients with NSCLC treated with curative intent, and decreased with age for patients receiving pa

39 those with both suicidal ideation and clear intent, and those with substance dependence.

40 Paranoia had a positive effect on harmful intent attribution, for both fair and unfair dictators.

41 Locoregional therapy with curative intent (CLRT) followed by salvage liver transplantation

42 rbidity on long-term survival after curative-intent CRC surgery remains controversial.

43 Demographic and intent data (1999-2013) were collected from the Centers

44 or palliative intent increased whereas other intents decreased significantly over time.

45 es, less frequent reconfirmation of donation intent, direct payment or funeral expense reimbursement,

46 f registration, frequency of confirmation of intent, direct payment, and funeral expense reimbursemen

47 Furthermore, emotional intent directly modulated functional connectivity of lim

48 Of these, 15 were treated with curative intent due to the presence of locoregional disease, and

49 re more likely to be treatable with curative intent (Dukes' A: 13/26, 50%; Dukes' B: 32/81, 40%; Duke

50 = 10.56; P = .003) and the subjective lethal intent factor (F1,25 = 10.63; P = .003; R2 = 0.32) based

51 ed good acceptability, with greater purchase intent for both products when added with chia mucilage d

52 transplantation (BMT) is used with curative intent for hematologic malignancies.

53 solid tumors, with therapeutic or palliative intents, for decades.

54 endogenous T cell response with therapeutic intent-for example, using blocking antibodies inhibiting

55 However, attributions of harmful intent have been poorly studied and mainly using artific

56 The intent here is not a legacy but an example.

57 S state for the years 2008-10 (stratified by intent [homicide and suicide]) from the US Centers for D

58 overall and according to race/ethnicity and intent in fatal and nonfatal firearm injuries (FFIs and

59 e than low AQ subjects signaling cooperative intent in games with fixed strategy agents while spendin

60 68)Ga-PSMA PET/CT imaging affects management intent in patients with primary or recurrent prostate ca

61 Our intent in this communication is not to minimize the impo

62 hese data, active surveillance with curative intent, in which active treatment is delayed until the c

63 EOL surgery for palliative intent increased whereas other intents decreased signifi

64 rimarily on the functional correlates of how intent information is neurally represented for moral jud

65 Much prior research asks how intent information is represented neurally, but little a

66 lized for firearm injury according to injury intent (intentional [assault] or unintentional [accident

67 In peripheral nerves, recording movement intent is challenging because motor axons are only a sma

68 Whereas the intent is to improve quality, there has been increasing

69 easurement to delivered dose and APSD if the intent is to predict the similarity of in vivo performan

70 Our intent is to provide a comprehensive overview of all wor

71 jury characteristics such as external cause, intent, location, and body part affected were reported f

72 ability to track the effectiveness of motor intent may constitute a computational building block for

73 stratification by country, age, radiotherapy intent, nodal status, and oestrogen receptor and HER-2 s

74 collaboration between investigators with the intent of achieving important innovations that would not

75 They communicate the affective state and intent of an individual and, if interpreted correctly, a

76 Whereas presumably an intent of BMI report cards was to slow BMI growth among

77 truction of malignant cells, the therapeutic intent of bone marrow transplantation.

78 ay expedite therapeutic development with the intent of bringing novel therapies to this patient popul

79 a virus Makona via different routes with the intent of comparing RNA-Seq to a NanoString nCounter cod

80 ast tomosynthesis (DBT) is provided with the intent of describing the state of the art in terms of te

81 hat hypofractionated radiotherapy failed the intent of either reducing physician-assessed late toxici

82 ctious diseases physician's profile with the intent of encouraging debate, discussion, and action.

83 resent excerpts of that translation with the intent of encouraging reevaluation of contemporary appro

84 attempt to avoid perceived dangers, and the intent of ERP is to extinguish compulsions.

85 ontrast (SPICA), has been developed with the intent of extracting potentially biologically relevant i

86 f death using only data from trials with the intent of fetal neuroprotection (RR 0.95, 95% CI 0.80 to

87 to diseases of the nervous system, with the intent of highlighting the role of these metabolites as

88 ing a phase 2.5 statistical design, with the intent of identifying a trend toward benefit (defined as

89 ow one to merge multiple assemblies with the intent of producing a higher quality consensus assembly,

90 of guano from a cave in NW Romania with the intent of reconstructing past variation in ECE hydroclim

91 developed a joint document with the primary intent of redefining CPX analysis and reporting in a way

92 s on research from the past decade, with the intent of showcasing the rapid emergence of this field a

93 suicidal behaviors, including lethality and intent of suicide attempts; and suicidal ideation.

94 The initial intent of the CBQC was to integrate these data and submi

95 olicies (7%) mentioned sun protection as the intent of the policy.

96 The intent of the Viewpoint is to summarize studies in rat O

97 The intent of this focus article is to provide a concise rev

98 The intent of this paper is to review the evidence supportin

99 The intent of this review is to develop the concept that the

100 The intent of this tutorial is to provide a useful backgroun

101 icted to data from the 4 trials in which the intent of treatment was fetal neuroprotection, there was

102 dictors of response to radiotherapy with the intent of ultimately moving toward using genomic and pro

103 s of lung aspirates and postmortem specimens intent on identifying pneumococcal disease to studies of

104 and for whom no suitable therapy of curative intent or higher priority existed from 13 centres.

105 itative behavior can occur without conscious intent or other higher-order cognitive process.

106 criteria consisted of suicidal or homicidal intent or psychosis.

107 cer ( P = .035), those treated with curative intent ( P = .003), and those with a lower CD4 cell coun

108 ded better therapeutic options with curative intent potential for some locoregional therapies.

109 included receiving treatment with palliative intent, preoperative RT, non-external-beam RT, and radia

110 y rectal cancer patients undergoing curative intent proctectomy at our institution between 2010 and 2

111 r lethal prostate cancer both after curative-intent prostatectomy and in a watchful waiting setting,

112 both administered concurrently with curative intent radiotherapy in patients with LAHNSCC.

113 ients who underwent NAT followed by curative-intent resection were matched by propensity score with p

114 68,463 eligible patients underwent curative-intent surgery and filled opioid prescriptions.

115 utilizing potentially beneficial, palliative-intent surgery and overutilizing cancer-directed and oth

116 al cohort of patients who underwent curative-intent surgery for ACC at 13 major institutions in the U

117 survival and recurrence risk after curative-intent surgery for ACC were selected to create nomograms

118 l (CDFS) for patients who underwent curative intent surgery for adrenocortical carcinoma (ACC).

119 ied patients with cancer undergoing curative-intent surgery from 2010 to 2014.

120 of new persistent opioid use after curative-intent surgery, identify risk factors, and describe chan

121 in patients with cancer undergoing curative-intent surgery.

122 ing treatment, after treatment with curative intent (survivorship), and after diagnosis with metastat

123 adiation treatment (62% change in management intent) than in patients undergoing primary staging (21%

124 danese at national and state levels with the intent that participants would become Ministry of Health

125 early-stage disease (presumably for curative intent), the outcomes were far worse (13.1, 18.9, 23.9%,

126 It is often amenable to curative intent therapy when localized to the head and neck regio

127 ce after primary PCa treatment with curative intent, three or fewer extracranial metastatic lesions o

128 moral judgments rely both on a perpetrator's intent to cause harm, and also on the actual harm caused

129 the inner section of the molecules with the intent to confer additional flexibility.

130 monitoring for disease progression with the intent to cure) appears to be safe and has become the pr

131 ccount for nearly one-third of attempts with intent to die (population attributable risk, 29.01%) in

132 were the presence of suicidal ideation with intent to die during the past week and/or a suicide atte

133 suicide attempts, particularly attempts with intent to die.

134 in AECs and to project unmet needs with the intent to enhance progress towards use of these faciliti

135 ders as a concise practical review, with the intent to facilitate good clinical practice.

136 However, with the intent to investigate both the composition of BAT and it

137 immunocytokines) have been designed with the intent to localize cytokine activity, systemic dose-limi

138 cations to undergo coronary angiography with intent to perform percutaneous coronary intervention.

139 tween December 2008 and August 2015 with the intent to perform TPVR.

140 geal cancer should be treated initially with intent to preserve the larynx by using endoscopic resect

141 unique pathogenesis of this virus; with the intent to rapidly develop vaccines and therapeutics.

142 Transition planning represents a serious intent to responsibly bring the world's largest global h

143 tion, organizational commitment, job search, intent to stay, and shock (back injuries) based on the l

144 job satisfaction, organizational commitment, intent to stay, and turnover, with some support for shoc

145 sping face can be seen as showing "fear" and intent to submit.

146 rticipants attributed equally strong harmful intent to the dictator in the observer role as in the re

147 nal Staging System stage (I, II, or III) and intent to transplant (yes vs no).

148 Analysis was based on modified intent to treat (randomized patients with >/=1 follow-up

149 randomized with 788 patients included in the intent to treat analysis (396 IPA and 392 chlorhexidine-

150 ulticenter randomized clinical trial with an intent to treat analysis.

151 Analyses were intent to treat and per protocol.

152 major depressive disorder were enrolled with intent to treat in the open-label study; 36 completed tr

153 A retrospective analysis of an intent to treat protocol was completed on United Network

154 Data were analyzed as intent to treat with linear mixed models and generalized

155 On intent to treat, 85% responded (3% complete response, 7%

156 dy provides the 5-year follow-up analyses by intent to treat, excluding one participant accepted for

157 With a median follow-up of 18.8 months, by intent to treat, the 1-year progression-free survival is

158 -CHOP or R-HDS arm, and 235 were analyzed by intent to treat.

159 Analysis was based on intent to treat.

160 Analysis was with intent to treat.

161 itivity undergoing coronary angiography with intent to undergo percutaneous coronary intervention.

162 All participants attributed more harmful intent to unfair as opposed to fair dictators.

163 cruited (2007 to 2011), 374 were analyzed by intent to-treat (184 patients on ET and 190 patients on

164 ilar among those starting both regimens (ie, intent-to treat hazard ratio [HR], 0.96 [95% confidence

165 nal hazards regression models were used with intent-to-treat (ITT) and exposure-only analyses.

166 Both intent-to-treat (ITT) and per-protocol (PP) analyses wer

167 l response (PCR-corrected ACPR) on day 28 in intent-to-treat (ITT) and per-protocol (PP) populations

168 ECR) assessed 3 days after first dose in the intent-to-treat (ITT) population.

169 s not met (effect size [ES] = 0.16, P = .42; intent-to-treat [ITT] mixed-effects model for repeated m

170 nts were randomly assigned and considered in intent-to-treat analyses (103 patients in arm A and 101

171 In intent-to-treat analyses at 26 weeks, the percentage of

172 Primary, mixed model, intent-to-treat analyses covaried for six genetic varian

173 We did mixed-effects, intent-to-treat analyses to examine treatment effects on

174 Intent-to-treat analyses were done for disease-free surv

175 Intent-to-treat analyses were performed February 28, 201

176 While intent-to-treat analyses yield null results, this explor

177 er they attended any treatment sessions (ie, intent-to-treat analyses), and no covariates still showe

178 's Health Insurance Program (CHIP) coverage (intent-to-treat analyses).

179 s maintenance fluids for 48 hours or longer (intent-to-treat analyses).

180 In intent-to-treat analyses, HSV shedding was detected in 2

181 In intent-to-treat analyses, we used linear mixed-effects m

182 Data were analyzed using intent-to-treat analyses.

183 an immunodeficiency virus (HIV) infection in intent-to-treat analyses.

184 Data were analyzed by intent-to-treat analyses.

185 111 placebo) in VISUAL-2 were studied using intent-to-treat analyses.

186 190 receiving formula) who were evaluated by intent-to-treat analysis (median birth weight, 1066 g; m

187 In an intent-to-treat analysis (n = 62), overall pCR was 27.4%

188 hundred eleven patients were included in an intent-to-treat analysis (TEG = 56, CCA = 55).

189 Overall, 29 of 37 (78%) in the intent-to-treat analysis achieved 4-SU (300-mg arm, 17 o

190 Intent-to-treat analysis did show an improvement in the

191 The intent-to-treat analysis included 1,460 patients (2,172

192 This intent-to-treat analysis included 721 children ages 2 to

193 An intent-to-treat analysis of overall survival (ITT-OS) of

194 s who received treatment were included in an intent-to-treat analysis of the response rate.

195 power to detect hazard ratio (HR), 0.714 by intent-to-treat analysis stratified by dose of RT at the

196 ional hazards models were used in a modified intent-to-treat analysis to compare hazard rates among t

197 l thromboembolic events were estimated in an intent-to-treat analysis using Cox regression models.

198 An intent-to-treat analysis was performed between October 2

199 An intent-to-treat analysis was performed between October 4

200 A modified intent-to-treat analysis was performed on participants w

201 Intent-to-treat analysis was performed.

202 Intent-to-treat analysis will be used to estimate the ef

203 In an intent-to-treat analysis with a median follow-up of 64 m

204 cebo in individuals with alcohol dependence (intent-to-treat analysis).

205 In an intent-to-treat analysis, clonidine produced the longest

206 In modified intent-to-treat analysis, mean baseline-adjusted endline

207 In an intent-to-treat analysis, significantly greater proporti

208 By intent-to-treat analysis, sustained virologic response a

209 By using intent-to-treat analysis, the placebo group had a higher

210 In intent-to-treat analysis, there was a trend for prebioti

211 t approach of PCS vs NACT, examined using an intent-to-treat analysis.

212 cipants in 3 years; 417 were in the modified intent-to-treat analysis.

213 1.15; 95% CI, 0.83 to 1.59; P = .41) in the intent-to-treat analysis.

214 placebo group) were included in the modified intent-to-treat analysis.

215 1.16; 95% CI, 0.79 to 1.71; P = .45) in the intent-to-treat analysis.

216 We performed an intent-to-treat analysis.

217 en therapy and were included in the modified intent-to-treat analysis.

218 enrolled, 22 patients were excluded from the intent-to-treat analysis.

219 eks after the end of treatment (SVR12) using intent-to-treat analysis.

220 18 months post-random assignment based on an intent-to-treat analysis.

221 s]; 45% women) were included in the modified intent-to-treat analysis.

222 patients were randomized and included in the intent-to-treat analysis; 137 were transplanted.

223 In both the intent-to-treat and completer samples, GSK561679 failed

224 Analyses were done in intent-to-treat and evaluable populations.

225 Intent-to-treat and on-treatment analyses were performed

226 ed variables, and present both observational intent-to-treat and per-protocol estimates.

227 dy dysmorphic disorder severity (in both the intent-to-treat and the completer groups) and insight, d

228 statistically different between groups on an intent-to-treat basis (p = 0.25).

229 After 4 cycles, on an intent-to-treat basis, 66.3% of the patients in the VTD

230 ee survival, and results were analyzed on an intent-to-treat basis.

231 All trial end points were analyzed on an intent-to-treat basis.

232 pic surgery, and robotic surgery (RS)] on an intent-to-treat basis.

233 Observational intent-to-treat cohort analysis using the Veterans Affai

234 This observational, intent-to-treat cohort was comprised of 4,365 genotype 1

235 d November 2012; all 78 participants who met intent-to-treat criteria completed through follow-up.

236 In the intent-to-treat CT population, CT (n = 417), compared wi

237 ave differential response trajectories using intent-to-treat data from both trials (n = 4706) along w

238 n assessment and were included in a modified intent-to-treat efficacy analysis.

239 Patients were stratified by intent-to-treat into open (OLAR) or minimally invasive L

240 The overall intent-to-treat minimal residual disease-negative (MRD(-

241 In an intent-to-treat model, multivariate analysis demonstrate

242 t in subgroups of age and sex and when using intent-to-treat or on-treatment analytic approaches.

243 Focusing on intent-to-treat outcomes, within-group posttreatment eff

244 rformed per protocol for efficacy and in the intent-to-treat patient population for safety.

245 the primary and secondary end points in the intent-to-treat population (ITT).

246 In the intent-to-treat population (n = 1,810) at Week 24 for tr

247 The intent-to-treat population (N = 312) included treatment-

248 In the intent-to-treat population (ruxolitinib, n = 64; placebo

249 d point was progression-free survival in the intent-to-treat population (significance threshold of .0

250 Analysis was by intent-to-treat population and performed in May 2013.

251 of this study was HIV seroconversion in the intent-to-treat population as estimated with Cox regress

252 The intent-to-treat population comprised 571 patients (141 i

253 Primary analyses were restricted to the intent-to-treat population eligible for CT (patients pro

254 responses) after each treatment cycle in the intent-to-treat population every 4 weeks starting at wee

255 eened, and 126 were randomized; the modified intent-to-treat population included 121 patients (51 wom

256 The intent-to-treat population included 225 participants, of

257 Median PFS in the unselected intent-to-treat population was 3.75 months with seribant

258 Median progression-free survival in the intent-to-treat population was 7.1 months (95% CI, 5.9-8

259 t was preceded by a 30-day washout (modified intent-to-treat population).

260 zed: placebo, n = 360; lifitegrast, n = 358 (intent-to-treat population).

261 Of 592 patients in the intent-to-treat population, 414 (69.9%) received second-

262 Analyses were conducted on the intent-to-treat population, and health outcome measures

263 In the intent-to-treat population, mean TNSS score for the subl

264 For the microbiological intent-to-treat population, the rates of clinical cure a

265 In a modified intent-to-treat population, there were no differences be

266 We assessed efficacy in the intent-to-treat population, which consisted of all patie

267 core for ADS-5102 vs placebo in the modified intent-to-treat population.

268 rmed using a stratified log-rank test in the intent-to-treat population.

269 model for repeated measures on the modified intent-to-treat population.

270 n the area of erythema at 48-72 hours in the intent-to-treat population.

271 Analysis was conducted with an intent-to-treat population.

272 Analysis was by intent-to-treat population.

273 ety population, and 307 were included in the intent-to-treat population.

274 near mixed-effects modeling in line with the intent-to-treat principle was used to examine how baseli

275 Analyses were based on the intent-to-treat principle.

276 1 to June 2012, and data were analyzed using intent-to-treat principles, including last observation c

277 ssion rates were similar for the two groups (intent-to-treat rates, 41.6% for the CBT group and 42.9%

278 In the intent-to-treat sample (N=61 in both groups), significan

279 The intent-to-treat sample comprised 120 remitters from phas

280 The intent-to-treat sample comprised 221 patients; 109 assig

281 y, and efficacy analyses all used a modified intent-to-treat sample comprising all participants who r

282 The intent-to-treat sample included 39 participants (ECT plu

283 alysis assessed outcome at week 24 among the intent-to-treat sample, with responders defined as havin

284 Propensity score-adjusted models and intent-to-treat sensitivity analyses gave comparable res

285 This intent-to-treat study was a randomized clinical trial pe

286 ith potential selection bias, we designed an intent-to-treat study, which controlled for nonadherence

287 In parallel, intent-to-treat survival from listing was lower in patie

288 ouble-blind, randomized, placebo-controlled, intent-to-treat trial in 199 individuals with pulmonary

289 In a non-intent-to-treat trial, 42 patients with MF and normal le

290 Sixty-five patients were implanted (intent-to-treat/safety population).

291 er included all patients undergoing curative-intent total gastrectomy for gastric adenocarcinoma betw

292 In total, 120 patients underwent curative-intent total gastrectomy for stage I through III gastric

293 tripled normalized costs following curative-intent total gastrectomy.

294 s: high if the primary treatment modality or intent was changed and medium if the radiotherapy techni

295 Contrary to our hypotheses, suicidal intent was not predicted by serotonin1A binding potentia

296 For each cancer type and intent, we calculated 30-day mortality rates and patient

297 exocrine pancreatic malignancy with curative intent were identified from a prospective database.

298 oing upfront surgical resection for curative intent were identified in the National Cancer Data Base

299 from 2000 to 2012 and treated with curative intent were included from the United States and Sweden (

300 uicide or experienced suicidal ideation with intent, were randomly assigned to treatment as usual (N=